Journals 2014
Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.
Cell Death and Differentiation.
2014,
21(2),
258-269,
ISSN: 1350-9047,
PMID: 24121277,
Functional genetic polymorphisms of monocyte chemoattractant protein 1 and C-C chemokine receptor type 2 in ischemic stroke.
Journal of Interferon and Cytokine Research.
2014,
34(2),
100-105,
ISSN: 1079-9907,
PMID: 24083412,
The effect of pars plan vitrectomy on oxygen saturation in retinal vessels - a pilot study.
Acta Ophtalmologica.
2014,
92(4),
328-331,
ISSN: 1755-375X,
PMID: 23848230,
Usefulness of PCR-HRMA in identification of non-fermentative Gram-negative rods recovered from patients suffering from cystic fibrosis or chronic obstructive pulmonary disease.
Folia Microbiologica (Praha).
2014,
59(1),
17-21,
ISSN: 0015-5632,
PMID: 23761199,
Omission of adjuvant radiation therapy in elderly patients with low risk breast cancer undergoing breast-conserving surgery--two center experience.
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic.
2014,
158(3),
461-464,
ISSN: 1213-8118,
PMID: 23681308,
The CRZ1/SP1-like gene links survival under limited aeration, cell integrity and biofilm formation in the pathogenic yeast Cryptococcus neoformans.
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic.
2014,
158(2),
212-220,
ISSN: 1213-8118,
PMID: 23640031,
Detection of minimal residual disease in lung cancer.
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic.
2014,
158(2),
189-193,
ISSN: 1213-8118,
PMID: 23558472,
The safety and efficacy of bridging full-dose IV-IA thrombolysis in acute ischemic stroke patients with MCA occlusion: A comparison with IV thrombolysis alone.
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic.
2014,
158(3),
391-396,
ISSN: 1213-8118,
PMID: 23446208,
Progression of macular atrophy after PDT combined with the COX-2 inhibitor Nabumetone in the treatment of neovascular ARMD.
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic.
2014,
158(1),
138-143,
ISSN: 1213-8118,
PMID: 23132511,